Page results
-
Alternatives to Accident and Emergency (A&E) and attending the Emergency Department (Casualty) at UCLH
-
This page provides general information about the procedure called lumbar decompression.
-
Become a member of UCLH. We want to better reflect the diversity of the communities we serve and meet the needs of our local community, patients and staff.
-
Information about the COVID-19 clinics available at UCLH.
-
UCLH patient information for using Control IQ technology
-
Brooke Robinson tells us what it is like to work to in neuroradiography at the National Hospital for Neurology and Neurosurgery.
-
At UCLH, we encourage self-referral to our antenatal service, but you also have the choice to go via your GP who will make the referral for you.
-
Care in the last days of life: information for families, friends and carers.
-
The spasticity service at NHNN offers a comprehensive, responsive multidisciplinary service to adults with spasticity associated with any neurological condition.
-
UCLH cancer services are closely located in and around University College Hospital, which is a one-minute walk from Warren Street and Euston Square tube stations. It’s a 15-minute walk from London King’s Cross St Pancras and Euston stations, and a few minutes on the Circle Line from Paddington Station.
File results
-
FOI/2022/0717 - Digital Healthcare organisation chart
-
FOI/2022/0718 - Clinical service incidents caused by estates and infrastructure in 2021/22
-
FOI/2022/0722 - Procedures for patients on lateral flow tests and wearing masks in hospital
-
FOI/2022/0723 - Spend on external companies for intraoperative neuromonitoring (IONM)
-
FOI/2022/0724 - Radiology enquiry - brain imaging, prostate, breast, Liver, Gynaecological scans within MRI
-
FOI/2022/0725 - High Acuity Monitoring - NCIU, Theatres, ICU
-
FOI/2022/0728 - Digital/ data team structures
-
FOI/2022/0730 - Outpatient unit day procedures for haematology patients
-
FOI/2022/0734 - A&E attendances for episodes of sunburn and/ or effects of heat and light
-
FOI/2022/0739 - Treatment of HR+ adjuvant breast cancer